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1. Introduction 
Viral transformation of normal cells in vitro is 
accompanied by a wide variety of chemical and bio- 
logical alterations of cell surface, including cross 
membrane transport [I]. For instance, Rous sarcoma 
virus (RSV)-transformed chick embryo fibroblasts 
(CEF) take up 2-deoxy-D-glucose (2-DG) or 3-0 
methyl-D-glucose much more rapidly than normal 
cells [2]. This is due to a structural change in the 
plasma membrane [3] and assumed to be an early 
event following infection [4]. 
In view of studying the relationship between trans- 
methylation and oncogenic cell transformation, many 
structural analogues of S-adenosylhomocysteine 
(SAH) have been synthesized in our laboratory [5]. 
One of these, 5’-deoxy-S’S-isobutylthioadenosine 
(SIBA)* was shown to inhibit cell transformation and 
replication of several oncogenic RNA and DNA 
viruses [6,7] as well as methylation of tRNA and 
proteins [8,9]. When the effect of SIBA on intra- 
cellular protein and nucleic acid synthesis was studied, 
a great decrease of the uptake of some radioactive 
precursors was observed. We thus examined the effect 
of SIBA on the uptake of nucleosides and of 2-DG in 
normal and RSV-transformed CEF. 
Our results show that the transport process, rather 
than the subsequent phosphorylation of these mole- 
* SIBA has been patented by ANVAR (Agence Nationale 
pour la Valorisation de la Recherchc, patent no. 75 177 972 
(1975)) 
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cules, is inhibited by the drug. The inhibition is 
reversible and identical in normal and transformed 
cells. However, the increase of 2-DG uptake by trans- 
formed cells is irreversibly inhibited by SIBA, when 
the drug remains in contact for 24 h with infected 
cells. As this compound inhibits the transport of 
structurally unrelated molecules, its effect may be 
due to an interaction with a membrane constituent, 
involving alterations in the transport systems of the 
cell. 
2. Materials and methods 
2.1 . Cells and viruses 
Growth of secondary CEF, in 35 mm Petri dishes, 
the infection by RSV and the media used were as in 
[6]. Uptake experiments were performed with 
6 X 10” cells/dish corresponding to 150 pg protein. 
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2.2. Inhibitors 
SIBA and SAH are products of Sefochem Fine 
Chemicals, Israel. 5’-deoxy-S’S-isobutylthioinosine 
(SIBI), 5’-deoxy-5’S-methyl-allylthioadenosine 
(SMAA) and 5’-deoxy-5’-S-isobutylthiouridine (SIBU) 
were synthesized in our laboratory by Dr P. Blanchard 
and Dr M. Vuilhorgne. 3-deaza-SIBA (3dSIBA) [lo] 
was a gift of Dr P. K. Chiang, NIH, Bethesda, MD. 
5-13H]uridine (U) 28 Ci/mM, [met/zyZ-3H]thymidine 
(T) 49 Ci/mM were purchased from the Commissariat 
a 1’Energie Atomique, Saclay, France. 
2.3. Nucleoside uptake 
This was measured by adding the adequate amount 
of radioactive precursor in 1 ml culture medium or 
phosphate-buffered saline (PBS) to each dish. After 
incubation at 37°C or at 20°C the liquid was removed, 
cells rinsed with cold PBS, and 1 ml cold 5% trichloro- 
acetic acid (TCA) was added per dish for 15 min. 
Radioactivity was counted in an aliquot of this 
(TCA)-soluble pool. Incorporation was then estimated 
after hydrolysing the cells in 1 ml 0.5 N NaOH at 
80°C for 15 mm. 
2.4. Transport of nucleosides 
This was measured after incubating the cells in 
50 mM 2-DG at 37°C for 30 min, followed by 2 
washes with PBS. This treatment reduces the intra- 
cellular level of ATP by -70%. Nucleosides cannot be 
phosphorylated under these conditions, so the intra- 
cellular radioactivity corresponds to transport [ Ill. 
The device used for the rapid labelling experiments 
(< 5 s) developed in our laboratory will be described 
elsewhere. 
2.5. The phosphorylated intermediates of nucleosides 
These were identified as in [ 121. 
2.6. Uridine and thymidine kinase 
Activity was measured in cell-free extracts by the 
method in [ 131. 
2.7. Hexose uptake 
Cultures were supplemented with 1 or 2 PCi 
2-Dt3H]G (20 Ci/mM, Amersham) in 1 ml PBS and 
incubated for 10 min at 20°C. Tracer was then 
removed, cells were washed with cold PBS and total 
sugar uptake was determined by measuring the radio- 
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activity in 100 ~1 cell hydrolysate as described for 
nucleosides. 
2.8. Phosphorylatiorz of 2-DC 
This was measured in cells incubated at 37°C for 
10 min with 2 mM 2-DG containing 2 pCi/ml of 
labelled sugar. The total amount of 2-DC + 2-DG-6- 
phosphate (2-DG-6-P) was solubilized in 1 ml boiling 
water for 1 min [ 141. Radioactivity in 50 ~1 of this 
fraction was counted. The amount of free sugar was 
estimated after selective precipitation of phospho- 
rylated sugar with BaS04 [3]. 
2.9. Hexokinase 
Activity was measured in cell-free extracts as in 
[3]. Proteins were determined by the Lowry proce- 
dure [15]. 
3. Results and discussion 
Experiments on the effect of SIBA on nucleic acid 
synthesis showed that the molecule interferes strongly 
with the uptake of radioactive precursors into the 
cells. As shown in fig.la the uptake of [3H]U into 
TCA-soluble and -insoluble cell fraction is affected to 
the same extent by different concentrations of SIBA; 
a: SH-u 
FIBA] mM 
Fig.1. Effect of increasing concentrations of SIBA on (a) 
uridinc (U) and (b) thymidinc (T) uptake by normal CEF. 
Tritiated precursor (2 &i) in 1 ml of Eagle’s medium with 
the indicated amount of SIBA were added to each plate and 
incubated at 37°C for 30 min. The cells were rinsed, and 
radioactivity in TCA-soluble (o---o) and TCA-prccipitable 
(o---0) fraction counted. The same results were obtained 
with transformed cells. Results are expressed in cpm/mg 
protein. 
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half-maximal inhibition was reached with 50 PM. The 
uptake of [3H]T into TCA-soluble material is inhibited 
to a lesser degree than incorporation into TCA-insol- 
uble fraction. The half maximal inhibition was 
reached, respectively, in the two fractions with 100 PM 
and 7.5 @I SIBA. Thus in this case an effect on DNA 
synthesis cannot be ruled out (fig.1 b). The phos- 
phorylation of both nucleosides was then studied 
in vitro and in whole cultures (table 1 A), 
Table 1A 
Effect of SIBA on phosphorylation of uridine and thymidinc 
in whole cells 
Metabolites Untreated 
cpm (70 total) 
Treated 
cpm (% total) 
U 
UMP 
UDP 
UTP 
Total counts 
2572 ( 53) 1002 ( 75) 
264 ( 5) 46 ( 3) 
1407 ( 29) 214 ( 16) 
613( 13) 64 ( 5) 
4856 (100) 1326 (100) 
T 
TMP 
TDP 
TTP 
Total counts 
95( 1) 115 ( 14) 
3210 ( 53) 502 ( 59) 
856 ( 14) 72( 8) 
1854 ( 31) 155 ( 18) 
6015 (100) 844 (100) 
Cultures of normal and transformed cells were exposed to 
Eagle’s medium containing 0.5 PM [‘HIT or 5 PM [“H]U 
(4 pCi/ml) with 1 mM and 0.5 mM, respectively, or without 
SIBA. Incubation time at 37°C was 15 min (normal cells) and 
30 min (transformed cells). Monolaycrs were rinsed with PBS, 
extracted with perchloric acid 0.5 N and the extract chro- 
matographed with unlabelled carriers. Spots wcrc localized, 
extracted with II,0 and counted 
Table 1B 
Effect of SIBA on phosphorylation of uridine and 
thymidine on the two kinases in vitro 
SIBA Uridine kinase Thymidinc kinase 
(mM) (pmol/mg protein/30 min) 
0 3.0 6.2 
0.10 3.2 6.3 
0.25 3.5 6.1 
0.50 3.3 6.8 
1.25 2.9 6.8 
Cell free extracts of normal and transformed cells were assayed 
for uridine and thymidine kinase activity by measurement of 
the amount of tritiated phosphorylated metabolites retained 
on positively charged filters, in the presence and absence of 
SIBA 
The reduced level of phosphorylated intermediates 
was at first thought to be due to the inhibition of the 
kinases by SIBA. However, as shown in table 1 B 
the drug has no effect on these enzymes in vitro even 
at 1.25 mM. Considering this fact we conclude that 
there is no direct action of SIBA on phosphorylating 
enzymes. We therefore measured the effect of the 
drug on nucleoside transport under conditions where 
no phosphorylation takes place, i.e., when there is 
rapid labelling and ATP depletion. Rapid labelling 
experiments (fig.%) demonstrated that 0.5 mM SIBA 
inhibits completely the transport of both nucleosides 
as early as 15 s. In table 2 the effects of different con- 
centrations of SIBA are compared on nucleoside 
transport process in phosphorylating and non-phos- 
phorylating (2-DG-treated) cells. With < 500 yM 
(0.5 mM) SIBA the inhibitions are identical and very 
strong (reaching 84695% at 500 FM) indicating that 
this compound affects mostly the transport process. 
Thus, SIBA has doubtlessly a very strong and 
quick effect on nucleoside transport. We can not 
explain at this stage of our work the reason for the 
reduced level of phosphorylated nucleosides in SIBA- 
treated cells. As the kinases are not affected this may 
be due to an indirect, unknown effect of the drug. 
One of the characteristic features of RSV-trans- 
Table 2 
Inhibition by SIBA of uridinc and thymidinc uptake in 
untreated (a) and ATPdepleted cells (b) 
SIBA U I 
(PM) a b a b 
_ 20960(p) 3215 (p) 100950(-) 11560(-) 
25 11 110 (47) 2515 (22) 56 745 (44) 7685 (34) 
50 9010 (57) 1350 (58) 38 410 (58) 5200 (55) 
100 6915 (67) 1120 (65) 30 520 (70) 3755 (68) 
200 4610 (78) 875 (73) 18 171 (82) 2312 (80) 
500 1675 (92) 175 (95) 13 123 (87) 1849 (84) 
Cells were incubated with 50 mM 2DG at 37°C for 30 min 
and labclled with 10 pCi/ml of U or T at 20°C for 30 s, (b) in 
order to measure the transport process alone. Phosphorylatinp 
cells were labclled for 10 min with 2 pCi/ml of U or T at 
20°C (a) in order to obtain maximum inhibition of all the 
events: transport, uptake and phosphorylation. SIBA at dif- 
ferent concentrations was added with the precursor. Radio- 
activity was measured in TCA-soluble pool (> 95% of total 
radioactivity). Results arc expressed in cpm/mg protein; 7n 
of inhibition arc given in brackets 
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Fig.2. Transport of uridine and thymidine in ATP-depleted cells. Cells were incubated with 50 mM 2-DG in 1 ml PBS at 37°C for 
30 mm, rinsed 2 times with PBS at room temperature, and [3H]U or [ 3H]T (10 pCi/ml PBS) were added. Radioactivity in soluble 
pool, containing > 95% of total cellular radioactivity, counted. (o----o) Without SIBA; (o----o) 0.5 mM SIBA. Results arc 
expressed in cpm/mg protein. 
formed cells is the increased uptake of 2-DG [2]. In centrations of free and phosphorylated 2-DG were 
the presence of 1 mM SIBA sugar uptake in normal determined in SIBA-treated cells, the proportion of 
or transformed cells was lowered by -80%. Phos- 2 DG-6-P with respect to 2-DG did not change 
phorylation in vitro was not affected. When the con- (table 3). 
Table 3 
Uptake and phosphorylation of 2deoxy-D-glucose in whole cells and 
phosphorylation by a cell-free extract in the presence and in the 
absence of SIBA 
SIBA (mM) 
0 0.25 0.5 1 
Uptake (nmol/mp protein) 122 97 13 40 
Free 2-DC (nmol/mg protein) 49 36 29 16 
2DG-6-P (nmol/mg protein) 73 61 44 24 
2DG 
0.67 0.59 0.66 0.61 
2DG-6P 
% inhibition of 
hexokinase in vitro _ 2 4 5 
Normal cells were loaded with 2 mM 2-D[3H]G (2 nCi/ml) in 1 ml PBS and incu- 
bated at 37°C for 10 mm. Then the total sugar was solubilized with 1 ml boiling 
water, and the amount of free 2-DG was determined by selective precipitation of 
phosphorylated sugar with BaSO,. Hexokinase activity in crude extracts was 
measured after 90 min incubation at 37’C. The reaction was stopped by Ba(OH), 
and the free 2-DG in the supernatant determined as above 
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Fig.3. The irreversible inhibition by SIBA of the increase of 2-DC uptake followinp infection. Normal cells were infected with 
RSV (0 time). After the adsorption of the virus (1 h), the medium was removed and 1 ml Eagle’s medium without (*---a) or 
with SIBA added: (c---o) 0.25 mM; (,~-~--~~fi) 0.5 mhl; (o-----w) 1 mM. After 24 h incubation the medium was removed from 
each dish (indicated by the arrow and R) and 1 ml medium without SIBA was added. Cells were further incubated at 37”C, and 
2-DG uptake was measured at indicated times as follows: medium was removed, and I PCi 2-D[ 311]G in ml PBS was added. After 
10 min incubation at 37”C, sugar uptake was measured as before. Results are expressed in cpm/m: protein. 
The increase of sugar uptake by RSV-transformed 
CEF is thought to be due to structural changes in the 
cell membrane [3]. To know whether the effect of 
SIBA on transformation parallels its effect on increase 
of sugar transport, cells were infected with RSV in 
order to obtain fully transformed cells in 5 days. As 
shown in fig.3 the rate of 2-DG uptake begins to 
increase after 48 h. On day 3 several Rous cells 
appeared and 96 h after infection 60% of the cells 
were transformed. The rate of 2-DG uptake at this 
time was 3-fold higher than in normal cells. It was 
shown [6] that 1 mM SIBA after a 24 h contact with 
infected cells inhibits further transformation at least 
for 8 days. Thus, different amounts of SIBA were 
added for 24 h to infected cells and sugar uptake was 
measured in the absence of the drug. As shown in 
fig.3, with 1 mM SIBA no significant increase in 
2-DG uptake occurred indicating that inhibition of 
cell transformation parallels the inhibition of increased 
Table 4 
Inhibition by adcnosine (A), S-adcnosylhomocysteine (SAH) 
and its synthetic analogucs of the uptake of uridinc and 
2-deoxy-Dglucose and of ccl1 transformation 
Compounds Uridine 2-Deoxy-D-glucose Ccl1 trans- 
I,, (PM) I,, CmM) formation 
I,, (mM) 
______. _ 
A 120 > 10 n.i. 
SAH > 1000 > 10 >I 
SIBA 30 0.6 0.2 
3d-SIBA 80 n.d. 0.1 
SIB1 140 > 10 >I 
SIBU 300 1.5 n.i. 
SMAA 10 0.7 0.1 
Analogues arc added with the radioactive precursor in PBS 
and incubated at 20°C for 10 min. Results are given in con- 
centrations producing 50% inhibition (Is,). Concentrations 
were 0.01 -~I mM for U uptake, 0.225 mM for 2-DG uptake 
and 0.05--l mM for cell transformation. n.d., not done; 
n.i., no inhibition. The analogues arc cnumeratcd in section 2 
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uptake. The effect of SIBA was concentration depen- 
dent. In order to know whether the effect on mem- 
brane permeability is related to the oncostatic action, 
the 1se of several synthetic analogues on U and 2-DC 
uptake as well as their effect on cell transformation 
was determined. As shown in table 4 the best 
inhibitors of cell transformation have the lowest Z,e 
concentration for both precursors. The fact that 
SIBA (and the other active analogues) inhibit the 
uptake of structurally unrelated molecules suggests an 
interaction between the drug and the cell surface. 
This can produce conformational changes in the 
membrane affecting to various extents transport pro- 
cesses and the virus receptors. The purification of a 
‘SIBA-binding membrane factor’ is now under way in 
our laboratory. 
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